Value chain stagesInput

Products 51 to 60 of 120

EverSweet™ by Evolva + Cargill
Biotech components: Plant
Business models: B2B + B2C
Country of production: Switzerland
Country of distribution: USA + Europe
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/09/13 15:54 (4 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: NASEM Database
Trading symbol: EVE (SWX)
Value chain stage: Input
Farnesene by Amyris
Biotech components: Fungus
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Input
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2019/05/15 15:45 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Open Release
Source: Web search
Trading symbol: BAS (ETR)
Value chain stage: Input
Fuelzyme 650 Alpha-amylase by BASF + Verenium
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Europe + Asia
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2019/05/15 15:45 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: BAS (ETR)
Value chain stage: Input
Fumaric Acid by GC Innovation America + Myriant
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/09/13 15:29 (4 years ago)
Known funding amount: 110,000,000 USD
Funding types: Government + Venture Capital
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Gen 3 technical and medical fiber by Kraig Biocraft Laboratories
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 1,200,000 USD
Funding types: Shareholder Investment + Government
Industry: Medical + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Fiber
Production process: Closed Production
Source: Web search
Trading symbol: KBLB (OTCQB)
Value chain stage: Input
Biotech components: Virus
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): University + Research Institution
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Genetic Security System by Wyss Institute + Harvard University
Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 3,700,000 USD
Funding types: Government
Industry: Security
Market status: Early Stage Concept
Organization type(s): Research Institution
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
GM Yeast to make Cannabis by University of California, Berkeley + Demetrix Inc.
Biotech components: Yeast
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:18 (3 years ago)
Date last modified: 2019/09/12 15:18 (3 years ago)
Known funding amount: 11,000,000 USD
Funding types: Venture Capital
Industry: Medical
Market status: Early Stage Concept
Organization type(s): Private Company + University
Product categories: Medicine
Production process: N/A
Source: Scientist Magazine
Trading symbol: N/A
Value chain stage: Input
Hexamethylenediamine by Rennovia
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 78,500,000 USD
Funding types: Venture Capital
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input